Cancer: Pathophysiology, Current Therapies, Clinical Trials, and Drug Development 2025

Cancer: Pathophysiology, Current Therapies, Clinical Trials, and Drug Development is organized by Pharmaceutical Education and Research Institute (PERI) and will be held from Mar 12 - 14, 2025.

Description:
Therapeutics for cancer are entering a new era, where precision approaches promise to revolutionize the way in this disease is treated. This comprehensive course reviews current and emerging drugs, immunotherapies, their application to specific cancer types, how to conduct clinical trials for oncologic therapies, and the drug development process for drug candidates leading to their approval. The US Food & and Drug Administration (FDA) regulatory considerations for oncology drugs, registration endpoints, and accelerated and breakthrough approval mechanisms are also covered.